Literature DB >> 9267318

Determination of urinary free cortisol by HPLC.

U Turpeinen1, H Markkanen, M Välimäki, U H Stenman.   

Abstract

We here report a reversed-phase HPLC method for the determination of free cortisol in human urine, using methylprednisolone as the internal standard. Before chromatography, samples were extracted with a C18 solid-phase extraction column and the steroids were separated on a LiChrospher 100 C18 column with a mobile phase of methanol/acetonitrile/water (43/3/54 by vol). Linearity, precision, and accuracy of the method were established. The detection limit was 10 pmol of cortisol, and total CVs were < 8%. With various solid-phase extraction columns the recovery of cortisol was 36-97%; recovery of the internal standard was 43-85%. Study of interference by 6 other steroids and metabolites and 24 drugs showed that carbamazepine and digoxin partly overlapped with cortisol, but this interference could be reduced by modification of the mobile phase. The HPLC method was compared with an RIA and an automated immunoassay method. The results obtained by HPLC averaged 40% of the RIA values.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9267318

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  Carbamazepine and false positive dexamethasone suppression tests for Cushing's syndrome.

Authors:  Ronald C W Ma; Wing Bun Chan; Wing Yee So; Peter C Y Tong; Juliana C N Chan; Chun Chung Chow
Journal:  BMJ       Date:  2005-02-05

2.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

Review 3.  Drug-induced endocrine and metabolic disorders.

Authors:  Ronald C W Ma; Alice P S Kong; Norman Chan; Peter C Y Tong; Juliana C N Chan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 4.  Drugs and HPA axis.

Authors:  Alberto Giacinto Ambrogio; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

5.  Measurement of urinary free cortisol by LC-MS-MS: adoption of a literature reference range and comparison with our current immunometric method.

Authors:  L Bianchi; B Campi; M R Sessa; G De Marco; E Ferrarini; R Zucchi; C Marcocci; P Vitti; L Manetti; A Saba; P Agretti
Journal:  J Endocrinol Invest       Date:  2019-04-22       Impact factor: 4.256

Review 6.  Surgical management of adrenocortical tumours.

Authors:  Barbra S Miller; Gerard M Doherty
Journal:  Nat Rev Endocrinol       Date:  2014-03-18       Impact factor: 43.330

7.  11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension.

Authors:  Carmen Campino; Cristian A Carvajal; Javiera Cornejo; Betty San Martín; Oliviero Olivieri; Giancesare Guidi; Giovanni Faccini; Francesco Pasini; Javiera Sateler; Rene Baudrand; Lorena Mosso; Gareth I Owen; Alexis M Kalergis; Oslando Padilla; Carlos E Fardella
Journal:  Endocrine       Date:  2009-10-31       Impact factor: 3.633

8.  Biomedical evaluation of cortisol, cortisone, and corticosterone along with testosterone and epitestosterone applying micellar electrokinetic chromatography.

Authors:  Tomasz Bączek; Ilona Olędzka; Lucyna Konieczna; Piotr Kowalski; Alina Plenis
Journal:  ScientificWorldJournal       Date:  2012-03-12

Review 9.  Steroid assays in paediatric endocrinology.

Authors:  John W Honour
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-02-01

10.  Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial.

Authors:  Jochen Schopohl; Feng Gu; Robert Rubens; Luc Van Gaal; Jérôme Bertherat; Monica Ligueros-Saylan; Andrew Trovato; Gareth Hughes; Luiz R Salgado; Marco Boscaro; Rosario Pivonello
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.